Old Well Partners, LLC Solid Biosciences Inc. Transaction History

Old Well Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$5.27 - $7.65 $56,915 - $82,620	10,800 New	10,800 $58,000
Q4 2021 Feb 14, 2022	SELL	$1.69 - $2.46 $57,316 - $83,430	-33,915 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.37 - $10.72 $182,123 - $363,568	33,915 New	33,915 $188,000
Q3 2020 Nov 16, 2020	SELL	$2.02 - $3.08 $20,246 - $30,870	-10,023 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$2.82 - $12.9 $28,264 - $129,296	10,023 New	10,023 $45,000

Ticker SLDB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 7,533,080
Market Cap $29.8M
Description
Solid Biosciences Inc. engages in developing therapies for duchenne muscular dystrophy in the United States. The company's lead product candidate is SGT-001, a gene transfer candidate, which is in a Phase I/II clinical trial to drive functional dystrophin protein expression in patients' muscles; and SGT-003, a ext-generation gene transfer candid...

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Old Well Partners, LLC with notifications on news.